Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2024 Filed Feb 28, 2024 21:37 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
Tax withholdingCommon Stock | 6,698 | $76.43 | $511,928.14 |
DisclosureSEC source: 0001127602-24-007442 · form4.xml · nonDerivative · entry 1 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,183 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:41 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 355 | $76.43 | $27,132.65 |
DisclosureSEC source: 0001127602-24-007457 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,333.9847 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:44 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
Tax withholdingCommon Stock | 261 | $76.43 | $19,948.23 |
DisclosureSEC source: 0001127602-24-007467 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,185.463 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 23:46 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
SaleCommon Stock | 29,473 | $76.95 | $2,267,947.35 |
DisclosureSEC source: 0001127602-24-005449 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,764.7624 F1 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between 76.93 to 76.99 per share. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:08 UTC |
Lynch Karen SDirector · President and CEO
|
GrantCommon Stock | 136,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005068 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,640 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:12 UTC |
Shah Prem SEVP and Pres-Pharm, Consumer W
|
GrantCommon Stock | 13,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005070 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,237.7624 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:13 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005071 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,150 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:14 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantCommon Stock | 16,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005073 · form4.xml · nonDerivative · entry 1 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,203 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:15 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantCommon Stock | 1,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005074 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,645.1867 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 21:46 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock (Restricted) | 122 | $68.48 | $8,354.56 |
DisclosureSEC source: 0001127602-23-029716 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,760 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| December 07, 2023 Filed Dec 9, 2023 00:30 UTC |
Finucane Anne A.Director
|
GiftCommon Stock | 3,450 | $74.28 | $256,266.00 |
DisclosureSEC source: 0001127602-23-029182 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,232.2482 F1 · kind: Gift of shares by the reporting person to a donor-advised charitable family foundation. Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 22:53 UTC |
COWHEY THOMAS F.SVP, Interim CFO
|
GrantCommon Stock (Restricted) | 7,358 | $67.95 | $499,976.10 |
DisclosureSEC source: 0001127602-23-028624 · form4.xml · nonDerivative · entry 1 COWHEY THOMAS F. · CIK 0001735242 · SVP, Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,938 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse on 11/30/2026. Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 22:54 UTC |
Kane Brian AEVP/President, Aetna
|
GrantStock Option · Derivative | 77,017 | $67.95 Strike: $67.95 | $5,233,305.15 |
DisclosureSEC source: 0001127602-23-028625 · form4.xml · derivative · entry 2 Kane Brian A · CIK 0001609525 · EVP/President, Aetna 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,017 Underlying: Common Stock · 77,017 shares Expires 2033-11-30 F1 · security: Option becomes exercisable in four equal annual installments, commencing 11/30/2024. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:42 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,998 | $69.13 | $138,121.74 |
DisclosureSEC source: 0001127602-23-027817 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,176 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:43 UTC |
Balser Jeffrey R.Director
|
GrantCommon Stock | 1,817 | $69.13 | $125,609.21 |
DisclosureSEC source: 0001127602-23-027819 · form4.xml · nonDerivative · entry 1 Balser Jeffrey R. · CIK 0001751633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,093 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:44 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,925.7197 | $69.13 Strike: $0.00 | $133,125.00 |
DisclosureSEC source: 0001127602-23-027822 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,483.6818 Underlying: Common Stock · 1,925.7197 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:45 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,817.2284 | $69.13 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-23-027825 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,199.6548 Underlying: Common Stock · 1,817.2284 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:46 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,925 | $69.13 | $133,075.25 |
DisclosureSEC source: 0001127602-23-027827 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,524 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:47 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 4,411.9774 | $69.13 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-23-027831 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,639.0157 Underlying: Common Stock · 4,411.9774 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:48 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,925 | $69.13 | $133,075.25 |
DisclosureSEC source: 0001127602-23-027832 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,682.2482 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:49 UTC |
KIRBY J SCOTTDirector
|
GrantCommon Stock | 2,422 | $69.13 | $167,432.86 |
DisclosureSEC source: 0001127602-23-027833 · form4.xml · nonDerivative · entry 1 KIRBY J SCOTT · CIK 0001249555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,721 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:51 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 2,422.97 | $69.13 Strike: $0.00 | $167,499.92 |
DisclosureSEC source: 0001127602-23-027839 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,522.672 Underlying: Common Stock · 2,422.97 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:52 UTC |
Mahoney Michael FDirector
|
GrantCommon Stock | 1,817 | $69.13 | $125,609.21 |
DisclosureSEC source: 0001127602-23-027844 · form4.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,817 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:53 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,925 | $69.13 | $133,075.25 |
DisclosureSEC source: 0001127602-23-027847 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,362 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:55 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,817.2284 | $69.13 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-23-027848 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,734.5362 Underlying: Common Stock · 1,817.2284 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 15:59 UTC |
LUDWIG EDWARD JDirector
|
PurchaseCommon Stock | 2,000 | $70.47 | $140,930.00 |
DisclosureSEC source: 0001127602-23-026822 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,630 Read SEC document |
| October 02, 2023 Filed Oct 2, 2023 21:42 UTC |
KIRBY J SCOTTDirector
|
GrantCommon Stock | 299 | $69.82 | $20,876.18 |
DisclosureSEC source: 0001127602-23-025029 · form4.xml · nonDerivative · entry 1 KIRBY J SCOTT · CIK 0001249555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 20:22 UTC |
Mandadi TilakEVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 13,053 | $65.17 | $850,664.01 |
DisclosureSEC source: 0001127602-23-023580 · form4.xml · nonDerivative · entry 1 Mandadi Tilak · CIK 0001872827 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,229 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 20:24 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 3,508 | $65.17 | $228,616.36 |
DisclosureSEC source: 0001127602-23-023583 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,987.7242 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 21:41 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 23,128 | $74.94 | $1,733,212.32 |
DisclosureSEC source: 0001127602-23-022036 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,698 F2 · price: Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 21:41 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 2,631.255 | $74.79 | $196,791.56 |
DisclosureSEC source: 0001127602-23-022036 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,826 F1 · price: Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:42 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,329.1733 | $69.31 Strike: $0.00 | $92,125.00 |
DisclosureSEC source: 0001127602-23-016318 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,715.372 Underlying: Common Stock · 1,329.1733 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:46 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,437.3828 | $69.31 Strike: $0.00 | $99,625.00 |
DisclosureSEC source: 0001127602-23-016323 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,674.4498 Underlying: Common Stock · 1,437.3828 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:47 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 3,917.1837 | $69.31 Strike: $0.00 | $271,500.00 |
DisclosureSEC source: 0001127602-23-016324 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,634.358 Underlying: Common Stock · 3,917.1837 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:47 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 2,068.6048 | $69.31 Strike: $0.00 | $143,375.00 |
DisclosureSEC source: 0001127602-23-016325 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,816.975 Underlying: Common Stock · 2,068.6048 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:49 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,329.1733 | $69.31 Strike: $0.00 | $92,125.00 |
DisclosureSEC source: 0001127602-23-016326 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,534.0707 Underlying: Common Stock · 1,329.1733 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:50 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,329 | $69.31 | $92,112.99 |
DisclosureSEC source: 0001127602-23-016328 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,178 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:51 UTC |
Balser Jeffrey R.Director
|
GrantCommon Stock | 1,329 | $69.31 | $92,112.99 |
DisclosureSEC source: 0001127602-23-016329 · form4.xml · nonDerivative · entry 1 Balser Jeffrey R. · CIK 0001751633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,276 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:52 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,437 | $69.31 | $99,598.47 |
DisclosureSEC source: 0001127602-23-016331 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,599 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:53 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,437 | $69.31 | $99,598.47 |
DisclosureSEC source: 0001127602-23-016333 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,757.2482 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:54 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,437 | $69.31 | $99,598.47 |
DisclosureSEC source: 0001127602-23-016334 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437 F1 · kind: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 03, 2023 Filed May 5, 2023 12:27 UTC |
Lynch Karen SDirector · President and CEO
|
PurchaseCommon Stock (By Trust) | 14,000 | $69.75 | $976,567.20 |
DisclosureSEC source: 0001127602-23-014615 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,392 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:24 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 40,825 | $74.31 Strike: $74.31 | $3,033,705.75 |
DisclosureSEC source: 0001127602-23-012212 · form4.xml · derivative · entry 7 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,825 Underlying: Common Stock · 40,825 shares Expires 2033-04-01 F6 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:24 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 1,854 | $74.31 | $137,770.74 |
DisclosureSEC source: 0001127602-23-012212 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,427.6327 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 9,649 | $74.31 Strike: $74.31 | $717,017.19 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · derivative · entry 10 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,649 Underlying: Common Stock · 9,649 shares Expires 2033-04-01 F11 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (Restricted) | 2,186 | $74.31 | $162,441.66 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,080 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:26 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 1,471 | $74.31 | $109,310.01 |
DisclosureSEC source: 0001127602-23-012216 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,457.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:27 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
GrantStock Option · Derivative | 74,228 | $74.31 Strike: $74.31 | $5,515,882.68 |
DisclosureSEC source: 0001127602-23-012221 · form4.xml · derivative · entry 10 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,228 Underlying: Common Stock · 74,228 shares Expires 2033-04-01 F7 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:27 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Tax withholdingCommon Stock | 3,856 | $74.31 | $286,539.36 |
DisclosureSEC source: 0001127602-23-012221 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,067.8088 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:28 UTC |
GUERTIN SHAWN MEVP & Chief Financial Officer
|
GrantStock Option · Derivative | 148,456 | $74.31 Strike: $74.31 | $11,031,765.36 |
DisclosureSEC source: 0001127602-23-012226 · form4.xml · derivative · entry 5 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,456 Underlying: Common Stock · 148,456 shares Expires 2033-04-01 F2 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.